Bringing the fundamentals into focus…
Back to Azenta, Inc.
How Azenta, Inc. stacks up
AZTA · against 588 other Healthcare companies listed in US-listed
Valuation
38/ 100
Above the middle of the pack.
Ranked #240 of 589 · scores higher than 59% of peers
Bars: peers in each 10-point band of the valuation score74 peers with a valuation score of 30–39, including AZTA · Click a bar to see the companies
Why valuation scores 38?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, which is weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -7.2% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 2.3% vs peer median 3.9%
- Free cash flow yield is close to the peer norm. Free cash flow yield: 0.6% vs peer median 0.0%
Metric by metric
Position: dot = AZTA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AZTA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -6.3% | -4.3% | 45% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 2.3% | -0.8% | 59% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 0.6% | -2.2% | 60% | 20% | |
| Book yieldHigher is better · 587 reported | 88.2% | 24.9% | 89% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around AZTA| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 247M USD | 98 | 80 | |
| 2 | 622M USD | 96 | 97 | |
| 2 | 441M USD | 96 | 81 | |
| 2 | 336M USD | 96 | 57 | |
| 2 | 817M USD | 96 | 69 | |
| 235 | 2.7B USD | 39 | 32 | |
| 235 | 393M USD |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score